CDC Anthrax | Laboratory Testing


Emergency Preparedness & Response

Agents, Diseases, & Other Threats

•

Bioterrorism Agents

Anthrax
•	Anthrax Basics:
	-	Questions & Answers
	-	Fact Sheets & Overviews
	-	Mail Handlers
•	In-Depth Info & Resources:
	-	Diagnosis/ Evaluation
	-	Environment/ Response
	-	Exposure Management/ Prophylaxis
	-	Images
	-	Infection Control
	-	Lab Testing
	-	Preparation & Planning
	-	References
	-	Surveillance & Investigation
	-	Training
	-	Treatment
	-	Vaccination
	-	Work Safety

•

Chemical Agents

•

Mass Trauma

•

Natural Disasters

•

Radiation Emergencies

•

Recent Outbreaks & Incidents

	Lab Information
	Training
	Preparation & Planning
	Surveillance
	Preparedness & Children
	News
	Related Links

Preparación y respuesta para casos de emergencia

Anthrax Home >

Anthrax: Laboratory Testing

Title	Date Last Revised
Q & A: Laboratory Testing For the public. Effectiveness, home test kits, getting screened, Mayo Clinic/Roche Rapid Anthrax test...	Jun 2, 2003
Q & A: Laboratory Safety Keeping lab workers safe...	Jun 2, 2003
Basic Diagnostic Testing Protocols for Level A Laboratories for the Presumptive Identification of Bacillus anthracis PDF (413 KB/18 pages) NOTE: Protocols for sentinel laboratories are no longer posted on the CDC website. The American Society for Microbiology has agreed to take the lead in the development & dissemination of sentinel laboratory information. Information for reference laboratories will continue to be available on the Laboratory Response Network secure website (for questions, e-mail lrn@cdc.gov; tollfree HelpDesk 1-866-LRN-LABS [1-866-576-5227]). The CDC subject matter experts on individual organisms remain available for discussion as always.	Mar 18, 2002
Ruling Out Bacillus anthracis NEW! Emerging Infectious Diseases 2004 Apr;10(4): 732-735 PDF (188 KB/4 pages)	Apr, 2004
Nonhemolytic, Nonmotile Gram-Positive Rods Indicative of Bacillus anthracis Emerging Infectious Diseases 2003 Aug;9(8):1013-1015.	Aug 2003
Laboratory Response to Anthrax Bioterrorism, New York City, 2001 Emerging Infectious Diseases 2002 Oct;8(10):1096-1102.	Oct 2002
Specific, Sensitive, & Quantitative Enzyme-Linked Immunosorbent Assay for Human Immunoglobulin G Antibodies to Anthrax Toxin Protective Antigen Emerging Infectious Diseases 2002 Oct;8(10):1103-1110.	Oct 2002
A Two-Component Direct Fluorescent-Antibody Assay for Rapid Identification of Bacillus anthracis Emerging Infectious Diseases 2002 Oct;8(10):1060-1065.	Oct 2002
*Molecular Subtyping of Bacillus anthracis* & the 2001 Bioterrorism-Associated Anthrax Outbreak, United States** Emerging Infectious Diseases 2002 Oct;8(10):1111-1116.	Oct 2002
Sequencing of 16S rRNA Gene: A Rapid Tool for Identification of Bacillus anthracis Emerging Infectious Diseases 2002 Oct;8(10):1117-1123.	Oct 2002
*Approved Tests for the Detection of Bacillus anthracis* in the U.S. Laboratory Response Network**	Jan 28, 2001
Acceptable Biological Specimens Needed for Testing for Anthrax	Dec 28, 2001
*Use of Onsite Technologies for Rapidly Assessing Environmental Bacillus anthracis* Contamination on Surfaces in Buildings** MMWR 2001 Dec 7;50(48):1087. PDF (144 KB/24 pages)	Dec 7, 2001
Recognition of Illness Associated with the Intentional Release of a Biologic Agent MMWR 2001 Oct 19;50(41):893-897. PDF (168 KB/20 pages)	Oct 19, 2001
Comprehensive Procedures for Collecting Environmental Samples for Culturing Bacillus anthracis	Apr 26, 2002
Hand-Held Immunoassays for Detection of Bacillus anthracis	Oct 18, 2001
Packaging Protocols for Biological Agents/Diseases PDF (61 KB/5 pages)	2001
Importance of Bacillus anthracis Molecular Subtyping During the Recent Multi-State Bioterrorism-Associated Anthrax Outbreak in the United States Archived video webcast from the International Conference on Emerging Infectious Diseases (ICEID) Alex Hoffmaster, CDC, Atlanta, GA	Mar 26, 2002
Rapid Adaptation of a Serologic Assay for the Bioterrorism-Related Anthrax Outbreak—October–December, 2001 Archived video webcast from the International Conference on Emerging Infectious Diseases (ICEID) Carolyn Greene, CDC, Atlanta, GA	Mar 26, 2002


		This page last reviewed August 2003